Western blot analysis of TP53 (phospho T18) polyclonal antibody (Cat # PAB0568) in mouse lung (left), mouse testis (right) tissue lysates. Phospho-TP53-T18 (arrow) was detected using the purified polyclonal antibody.
Western Blot (Cell lysate)
Western blot analysis of TP53 (phospho T18) polyclonal antibody (Cat # PAB0568) in, from left to right, A2058, Ramos and HL-60 cell lysate. Phospho-TP53-T18 (arrow) was detected using the purified polyclonal antibody.
Formalin-fixed and paraffin-embedded human hepatocellular carcinoma tissue reacted with TP53 (phospho T18) polyclonal antibody (Cat # PAB0568) which was peroxidase-conjugated to the secondary antibody followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. HC = hepatocarcinoma.
Dot Blot (Peptide)
Dot blot analysis of TP53 (phospho T18) polyclonal antibody (Cat # PAB0568) on nitrocellulose membrane. 50 ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.5 ug/mL.
This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. Mutants of p53 that frequently occur in a number of different human cancers fail to bind the consensus DNA binding site, and hence cause the loss of tumor suppressor activity. Alterations of this gene occur not only as somatic mutations in human malignancies, but also as germline mutations in some cancer-prone families with Li-Fraumeni syndrome. Multiple p53 variants due to alternative promoters and multiple alternative splicing have been found. These variants encode distinct isoforms, which can regulate p53 transcriptional activity. [provided by RefSeq
p53 antigen,p53 transformation suppressor,p53 tumor suppressor,phosphoprotein p53,transformation-related protein 53